Education
About Us
Working with TipRanks
Follow Us
MAIA Biotechnology, Inc. (MAIA)
:MAIA
MAIA Stock Chart & Stats
$1.35
-$0.33(-13.87%)
At close: 4:00 PM EST
$1.35
-$0.33(-13.87%)
Day’s Range― - ―
52-Week Range$0.87 - $2.74
Previous CloseN/A
Volume259.27K
Average Volume (3M)570.23K
Market Cap
$45.55M
Enterprise Value$58.45M
Total Cash (Recent Filing)$10.89M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.11
Shares Outstanding37,032,307
10 Day Avg. Volume650,834
30 Day Avg. Volume570,232
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)12.09
Price to Sales (P/S)0.00
P/FCF Ratio-2.80
Enterprise Value/Market Cap1.28
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-5.77
Forecast
1Y Price Target
$14.00Price Target Upside937.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MAIA Biotechnology, Inc. News
MAIA FAQ
What was MAIA Biotechnology, Inc.’s price range in the past 12 months?
MAIA Biotechnology, Inc. lowest stock price was $0.87 and its highest was $2.74 in the past 12 months.
What is MAIA Biotechnology, Inc.’s market cap?
MAIA Biotechnology, Inc.’s market cap is $45.55M.
When is MAIA Biotechnology, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MAIA Biotechnology, Inc.’s earnings last quarter?
Currently, no data Available
Is MAIA Biotechnology, Inc. overvalued?
According to Wall Street analysts MAIA Biotechnology, Inc.’s price is currently Undervalued.
Does MAIA Biotechnology, Inc. pay dividends?
MAIA Biotechnology, Inc. does not currently pay dividends.
What is MAIA Biotechnology, Inc.’s EPS estimate?
MAIA Biotechnology, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MAIA Biotechnology, Inc. have?
MAIA Biotechnology, Inc. has 37,032,307 shares outstanding.
What happened to MAIA Biotechnology, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MAIA Biotechnology, Inc.?
Currently, no hedge funds are holding shares in MAIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MAIA Biotechnology, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (937.04% Upside)
$14.00 (937.04% Upside)
Insider Transactions
Bought Shares
Worth $208.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 12.3%
Last 30 Days ▲ 23.3%
Last 30 Days ▲ 23.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.10%
12-Months-Change
Fundamentals
Return on Equity
-2691.06%
Trailing 12-Months
Asset Growth
-8.10%
Trailing 12-Months
Company Description
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. (MAIA) is a clinical-stage biopharmaceutical company focused on developing innovative oncology treatments. The company specializes in advancing targeted therapies that address unmet medical needs in cancer treatment, particularly leveraging its proprietary technology platform to develop novel therapies for various types of cancer.
MAIA Stock 12 Month Forecast
Average Price Target
$14.00
▲(937.04% Upside)
Technical Analysis
Veru
―
Applied Therapeutics
―
OnKure Therapeutics
―
Xilio Therapeutics
―
Radiopharm Theranostics Limited Sponsored ADR
―
Ownership Overview
12.99% Insiders
3.08% Mutual Funds
1.70% Other Institutional Investors
79.62% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---